Mesoblast Ltd
ASX:MSB

Watchlist Manager
Mesoblast Ltd Logo
Mesoblast Ltd
ASX:MSB
Watchlist
Price: 2.14 AUD -2.73%
Market Cap: 2.7B AUD
Have any thoughts about
Mesoblast Ltd?
Write Note

Wall Street
Price Targets

MSB Price Targets Summary
Mesoblast Ltd

Wall Street analysts forecast MSB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MSB is 3.17 AUD with a low forecast of 2.42 AUD and a high forecast of 4.52 AUD.

Lowest
Price Target
2.42 AUD
13% Upside
Average
Price Target
3.17 AUD
48% Upside
Highest
Price Target
4.52 AUD
111% Upside
Mesoblast Ltd Competitors:
Price Targets
068270
Celltrion Inc
32% Upside
NVAX
Novavax Inc
144% Upside
TECX
AVROBIO Inc
360% Upside
002252
Shanghai RAAS Blood Products Co Ltd
1% Upside
MRNA
Moderna Inc
70% Upside
SNDX
Syndax Pharmaceuticals Inc
180% Upside
MCRB
Seres Therapeutics Inc
434% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
8% Downside

Revenue
Forecast

Revenue Estimate
Mesoblast Ltd

For the last 8 years the compound annual growth rate for Mesoblast Ltd's revenue is -22%. The projected CAGR for the next 3 years is 282%.

-22%
Past Growth
282%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Mesoblast Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Net Income
Forecast

Net Income Estimate
Mesoblast Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MSB's stock price target?
Price Target
3.17 AUD

According to Wall Street analysts, the average 1-year price target for MSB is 3.17 AUD with a low forecast of 2.42 AUD and a high forecast of 4.52 AUD.

What is Mesoblast Ltd's Revenue forecast?
Projected CAGR
282%

For the last 8 years the compound annual growth rate for Mesoblast Ltd's revenue is -22%. The projected CAGR for the next 3 years is 282%.

Back to Top